Published in Cardiovasc Res on April 01, 1993
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest (2004) 4.97
Adenosine receptors and reperfusion injury of the heart. Handb Exp Pharmacol (2009) 1.06
Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning. World J Gastroenterol (2004) 1.04
Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol (1994) 0.89
Donors of nitric oxide mimic effects of ischaemic preconditioning on reperfusion induced arrhythmias in isolated rat heart. Mol Cell Biochem (1997) 0.87
Intravascular ATP and coronary vasodilation in the isolated working rat heart. Br J Pharmacol (1999) 0.83
AICAR inhibits the Na+/H+ exchanger in rat hearts--possible contribution to cardioprotection. Pflugers Arch (2006) 0.79
Suppression of reperfusion arrhythmia by ischemic preconditioning in the rat: is it mediated by the adenosine receptor, prostaglandin, or bradykinin receptor? Basic Res Cardiol (1995) 0.79
The role of myocardial ischaemic preconditioning during beating heart surgery: biological aspect and clinical outcome. Interact Cardiovasc Thorac Surg (2011) 0.78
Endothelin-1 exerts a preconditioning-like cardioprotective effect against ischaemia/reperfusion injury via the ET(A) receptor and the mitochondrial K(ATP) channel in the rat in vivo. Br J Pharmacol (2005) 0.78
Insights into the cardioprotective function of adenosine A(1) and A(3) receptors. Exp Clin Cardiol (2002) 0.76
A model of anoxic preconditioning in the isolated rat cardiac myocyte. Importance of adenosine and insulin. Basic Res Cardiol (1996) 0.75
Hypoxic preconditioning in isolated rat hearts: non-involvement of activation of adenosine A1 receptor, Gi protein, and ATP-sensitive K+ channel. Heart Vessels (1995) 0.75
Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats. Br J Pharmacol (1995) 0.75
Preconditioning--a reappraisal of protection. Basic Res Cardiol (1996) 0.75
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation (1991) 4.30
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res (1988) 3.98
Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res (2000) 3.19
Ischaemic preconditioning: can the protection be bottled? Lancet (1993) 2.33
Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol (2000) 2.28
Myocardial ischaemia: can we agree on a definition for the 21st century? Cardiovasc Res (1994) 2.16
Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol (1997) 2.15
Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation (1992) 2.08
Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol (1994) 2.04
Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol (1984) 2.00
Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol (1985) 2.00
The oxygen paradox and the calcium paradox: two facets of the same problem? J Mol Cell Cardiol (1978) 1.95
Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res (1987) 1.83
Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol (1973) 1.77
Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res (1995) 1.75
Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res (1987) 1.74
Reperfusion of the ischemic myocardium. J Mol Cell Cardiol (1977) 1.74
Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res (1994) 1.62
Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol (1999) 1.61
Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol (1977) 1.61
Serum total antioxidant activity after myocardial infarction. Ann Clin Biochem (1997) 1.56
Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res (1986) 1.52
The influence of some physico-chemical factors on the biliary excretion of a series of structurally related aryl sulphate esters. Biochem Pharmacol (1969) 1.51
Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol (2001) 1.49
No confirmation for a causal role of volume-regulated chloride channels in ischemic preconditioning in rabbits. J Mol Cell Cardiol (2000) 1.49
Oxygen deprivation and early myocardial contractile failure: a reassessment of the possible role of adenosine triphosphate. Am J Cardiol (1979) 1.48
The antiarrhythmic action of ischaemic preconditioning in rat hearts does not involve functional Gi proteins. Cardiovasc Res (1993) 1.46
Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res (2001) 1.43
Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart. J Thorac Cardiovasc Surg (1989) 1.43
Optimal myocardial protection during crystalloid cardioplegia. Interrelationship between volume and duration of infusion. J Thorac Cardiovasc Surg (1988) 1.43
Left ventricular unloading during reperfusion does not limit myocardial infarct size. Circulation (1990) 1.43
Inhibition of coronary blood flow by a vascular waterfall mechanism. Circ Res (1975) 1.41
Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res (1984) 1.39
Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol (1990) 1.39
Harvesting hearts for long-term preservation. Detrimental effects of initial hypothermic infusion of cardioplegic solutions. J Thorac Cardiovasc Surg (1990) 1.38
Intravenous co-infusion of adenosine and norepinephrine preconditions the heart without adverse hemodynamic effects. J Thorac Cardiovasc Surg (1997) 1.38
Signal transduction of ischemic preconditioning. Cardiovasc Res (2001) 1.38
Reduction of myocardial ischemic injury with oxygen-derived free radical scavengers. Surgery (1983) 1.38
Preconditioning: state of the art myocardial protection. Cardiovasc Res (1993) 1.35
Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol (1987) 1.35
The isolated blood and perfusion fluid perfused heart. Pharmacol Res (2000) 1.34
Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol (1999) 1.33
Ischemic preconditioning protects against infarction in rat heart. Am J Physiol (1992) 1.30
Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol (1994) 1.29
Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation (1991) 1.29
Pulmonary capillary pressure: a review. Crit Care Med (1992) 1.27
Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? Acta Physiol Scand Suppl (1986) 1.26
Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology (1997) 1.26
Hypothermic arrest and potassium arrest: metabolic and myocardial protection during elective cardiac arrest. Circ Res (1975) 1.25
Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res (1994) 1.24
Ischaemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol (1989) 1.23
Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol (1994) 1.23
Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol (1997) 1.22
Ischemic preconditioning: from basic mechanisms to clinical applications. Pharmacol Ther (2000) 1.21
The role of glucose in the survival and 'recovery' of the anoxic isolated perfused rat heart. Biochem J (1972) 1.20
Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol (1995) 1.18
The "border zone" in evolving myocardial infarction: controversy or confusion? Am J Cardiol (1981) 1.14
Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in the rat heart. Possible evidence of endothelial damage. J Thorac Cardiovasc Surg (1989) 1.13
Creatine kinase isoenzymes: their separation and quantitation. Cardiovasc Res (1977) 1.12
Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase. Biochem J (1973) 1.12
Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol (2000) 1.10
Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates. J Thorac Cardiovasc Surg (1977) 1.09
Free radicals and reperfusion-induced arrhythmias: protection by spin trap agent PBN in the rat heart. Circ Res (1987) 1.08
Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction? Basic Res Cardiol (1998) 1.08
Regulation of sarcolemmal Na(+)/H(+) exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT(1) versus AT(2) receptors. Circ Res (1999) 1.07
Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination? Arch Mal Coeur Vaiss (2007) 1.06
Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardiol (1975) 1.06
alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res (1994) 1.05
Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton. Am J Physiol (1999) 1.05
Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res (1996) 1.04
Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts. Am J Physiol (1987) 1.04
Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol (1989) 1.04
Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res (1994) 1.03
Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res (2000) 1.03
Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation (1976) 1.03
Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation (1993) 1.02
Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart. Basic Res Cardiol (1999) 1.02
Enzyme release during myocardial anoxia: a study of metabolic protection. J Mol Cell Cardiol (1975) 1.01
Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts. Cardiovasc Res (1985) 1.01
Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovasc Res (1998) 1.01
Ischemia-induced and reperfusion-induced arrhythmias: importance of heart rate. Am J Physiol (1989) 1.00
Distribution of the coronary blood flow across the canine heart wall during systole. Circ Res (1974) 0.99
Recovery from cardiac bypass and elective cardiac arrest. The metabolic consequences of various cardioplegic procedures in the isolated rat heart. Circ Res (1974) 0.99
Cardioprotection by Cu,Zn-superoxide dismutase is lost at high doses in the reoxygenated heart. Free Radic Biol Med (1990) 0.99
The calcium paradox: metabolic, electrophysiological, contractile and ultrastructural characteristics in four species. Eur J Cardiol (1978) 0.99
Progression of myocardial infarction in a collateral flow deficient species. Jpn Heart J (1989) 0.98
Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg (1977) 0.98
The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun (1998) 0.97
Amp 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors. J Cardiovasc Pharmacol (2001) 0.97
Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol (1993) 0.97
Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg (1978) 0.97
Temporal and spatial characteristics of evolving cell injury during regional myocardial ischemia in the dog: the "border zone" controversy. J Am Coll Cardiol (1983) 0.96
Effects of myocardial strains on coronary blood flow. Circ Res (1974) 0.96
The effects of nitroglycerin on coronary collaterals and myocardial contractility. J Clin Invest (1973) 0.96
Brain death-induced impairment of cardiac contractile performance can be reversed by explantation and may not preclude the use of hearts for transplantation. Circ Res (1992) 0.96
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts. Am J Cardiol (1983) 0.94
Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation (1993) 0.94
Diabetes and the survival and recovery of the anoxic myocardium. J Mol Cell Cardiol (1975) 0.94